Concord Biotech Limited — Others, 08-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Concord Biotech Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company’s registrar and share transfer agent, MUFG Intime India Pvt Ltd, confirmed that all securities received for dematerialisation during the quarter were processed timely, with certificates verified, mutilated, and cancelled as required, and no new dematerialisation or rematerialisation requests were received. This update ensures proper shareholding records and reflects smooth share management operations, maintaining investor confidence.